SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Zmuda JM Sheu YT Moffett SP 2005 Genetic epidemiology of osteoporosis: Past, present, and future. Curr Osteoporos Rep 3: 111115.
  • 2
    Diaz MN O' Neill TW Silman AJ 1997 The influence of family history of hip fracture on the risk of vertebral deformity in men and women: The European Vertebral Osteoporosis Study. Bone 20: 145149.
  • 3
    Fox KM Cummings SR Powell-Threets K Stone K 1998 Family history and risk of osteoporotic fracture. Osteoporos Int 8: 557562.
  • 4
    Johnson ML Gong G Kimberling W Recker SM Kimmel DB Recker RR 1997 Linkage of a gene causing high bone mass to human chromosome 11 (11q12-13). Am J Hum Genet 60: 13261332.
  • 5
    Little RD Carulli JP Del Mastro RG Dupuis J Osborne M Folz C Manning SP Swain PM Zhao SC Eustace B Lappe MM Spitzer L Zweier S Braunschweiger K Benchekroun Y Hu X Adair R Chee L FitzGerald MG Tulig C Caruso A Tzellas N Bawa A Franklin B McGuire S Nogues X Gong G Allen KM Anisowicz A Morales AJ Lomedico PT Recker SM Van Eerdewegh P Recker RR Johnson ML 2002 A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait. Am J Hum Genet 70: 1119.
  • 6
    Boyden LM Mao J Belsky J Mitzner L Farhi A Mitnick MA Wu D Insogna K Lifton RP 2002 High bone density due to a mutation in LDL-receptor-related protein 5. N Engl J Med 346: 15131521.
  • 7
    Gong Y Slee RB Fukai N Rawadi G Roman-Roman S Reginato AM Wang H Cundy T Glorieux FH Lev D Zacharin M Oexle K Marcelino J Suwairi W Heeger S Sabatakos G Apte S Adkins WN Allgrove J Arslan-Kirchner M Batch JA Beighton P Black GC Boles RG Boon LM Borrone C Brunner HG Carle GF Dallapiccola B De Paepe A Floege B Halfhide ML Hall B Hennekam RC Hirose T Jans A Juppner H Kim CA Keppler-Noreuil K Kohlschuetter A LaCombe D Lambert M Lemyre E Letteboer T Peltonen L Ramesar RS Romanengo M Somer H Steichen-Gersdorf E Steinmann B Sullivan B Superti-Furga A Swoboda W van den Boogaard MJ Van Hul W Vikkula M Votruba M Zabel B Garcia T Baron R Olsen BR Warman ML The Osteoporosis-Pseudoglioma Syndrome Collaborative 2001 LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell 107: 513523.
  • 8
    Babij P Zhao W Small C Kharode Y Yaworsky PJ Bouxsein ML Reddy PS Bodine PV Robinson JA Bhat B Marzolf J Moran RA Bex F 2003 High bone mass in mice expressing a mutant LRP5 gene. J Bone Miner Res 18: 960974.
  • 9
    Koller DL Rodriguez LA Christian JC Slemenda CW Econs MJ Hui SL Morin P Conneally PM Joslyn G Curran ME Peacock M Johnston CC Foroud T 1998 Linkage of a QTL contributing to normal variation in bone mineral density to chromosome 11q12-13. J Bone Miner Res 13: 19031908.
  • 10
    Ferrari SL Deutsch S Choudhury U Chevalley T Bonjour JP Dermitzakis ET Rizzoli R Antonarakis SE 2004 Polymorphisms in the low-density lipoprotein receptor-related protein 5 (LRP5) gene are associated with variation in vertebral bone mass, vertebral bone size, and stature in whites. Am J Hum Genet 74: 866875.
  • 11
    Koller DL Ichikawa S Johnson ML Lai D Xuei X Edenberg HJ Conneally PM Hui SL Johnston CC Peacock M Foroud T Econs MJ 2005 Contribution of the LRP5 gene to normal variation in peak BMD in women. J Bone Miner Res 20: 7580.
  • 12
    van Meurs JB Rivadeneira F Jhamai M Hugens W Hofman A van Leeuwen JP Pols HA Uitterlinden AG 2006 Common genetic variation of the low-density lipoprotein receptor-related protein 5 and 6 genes determines fracture risk in elderly white men. J Bone Miner Res 21: 141150.
  • 13
    Kiel DP Ferrari SL Cupples LA Karasik D Manen D Imamovic A Herbert AG Dupuis J 2007 Genetic variation at the low-density lipoprotein receptor-related protein 5 (LRP5) locus modulates Wnt signaling and the relationship of physical activity with bone mineral density in men. Bone 40: 587596.
  • 14
    van Meurs JB Trikalinos TA Ralston SH Balcells S Brandi ML Brixen K Kiel DP Langdahl BL Lips P Ljunggren O Lorenc R Obermayer-Pietsch B Ohlsson C Pettersson U Reid DM Rousseau F Scollen S Van Hul W Agueda L Akesson K Benevolenskaya LI Ferrari SL Hallmans G Hofman A Husted LB Kruk M Kaptoge S Karasik D Karlsson MK Lorentzon M Masi L McGuigan FE Mellström D Mosekilde L Nogues X Pols HA Reeve J Renner W Rivadeneira F van Schoor NM Weber K Ioannidis JP Uitterlinden AG 2008 Large-scale analysis of association between LRP5 and LRP6 variants and osteoporosis. JAMA. 299: 127790.
  • 15
    Richards JB Rivadeneira F Inouye M Pastinen TM Soranzo N Wilson SG Andrew T Falchi M Gwilliam R Ahmadi KR Valdes AM Arp P Whittaker P Verlaan DJ Jhamai M Kumanduri V Moorhouse M van Meurs JB Hofman A Pols HA Hart D Zhai G Kato BS Mullin BH Zhang F Deloukas P Uitterlinden AG Spector TD 2008 Bone mineral density, osteoporosis, and osteoporotic fractures: A genome-wide association study. Lancet 371: 15051512.
  • 16
    Bennett CN Longo KA Wright WS Suva LJ Lane TF Hankenson KD MacDougald OA 2005 Regulation of osteoblastogenesis and bone mass by Wnt10b. Proc Natl Acad Sci USA 102: 33243329.
  • 17
    Glynn NW Meilahn EN Charron M Anderson SJ Kuller LH Cauley JA 1995 Determinants of bone mineral density in older men. J Bone Miner Res 10: 17691777.
  • 18
    Hill DD Cauley JA Sheu Y Bunker CH Patrick AL Baker CE Beckles GL Wheeler VW Zmuda JM 2008 Correlates of bone mineral density in men of African ancestry: The Tobago Bone Health Study. Osteoporos Int 19: 227234.
  • 19
    Miljkovic-Gacic I Ferrell RE Patrick AL Kammerer CM Bunker CH 2005 Estimates of African, European and Native American ancestry in Afro-Caribbean men on the island of Tobago. Hum Hered 60: 129133.
  • 20
    Wang X Kammerer CM Wheeler VW Patrick AL Bunker CH Zmuda JM 2007 Genetic and environmental determinants of volumetric and areal BMD in multi-generational families of African ancestry: The Tobago Family Health Study. J Bone Miner Res 22: 527536.
  • 21
    Schiessl H Ferretti JL Tysarczyk-Niemeyer G Willnecker J 1996 Noninvasive bone strength index as analyzed by peripheral quantitative computed tomography (pQCT). SchoneauE (ed.) Paediatric Osteology: New Developments in Diagnostics and Therapy. Elsevier, Amsterdam, The Netherlands 141146.
  • 22
    Kruglyak L Nickerson DA 2001 Variation is the spice of life. Nat Genet 27: 234236.
  • 23
    Rinaldo A Bacanu SA Devlin B Sonpar V Wasserman L Roeder K 2005 Characterization of multilocus linkage disequilibrium. Genet Epidemiol 28: 193206.
  • 24
    Yuan HY Chiou JJ Tseng WH Liu CH Liu CK Lin YJ Wang HH Yao A Chen YT Hsu CN 2006 FASTSNP: An always up-to-date and extendable service for SNP function analysis and prioritization. Nucleic Acids Res 34: W635W641.
  • 25
    Devlin B Risch N 1995 A comparison of linkage disequilibrium measures for fine-scale mapping. Genomics 29: 311322.
  • 26
    Stephens M Smith NJ Donnelly P 2001 A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 68: 978989.
  • 27
    Almasy L Blangero J 1998 Multipoint quantitative-trait linkage analysis in general pedigrees. Am J Hum Genet 62: 11981211.
  • 28
    Jiang R Duan J Windemuth A Stephens JC Judson R Xu C 2003 Genome-wide evaluation of the public SNP databases. Pharmacogenomics 4: 779789.
  • 29
    Ferretti JL Capozza RF Zanchetta JR 1996 Mechanical validation of a tomographic (pQCT) index for noninvasive estimation of rat femur bending strength. Bone 18: 97102.
  • 30
    Krishnan V Bryant HU Macdougald OA 2006 Regulation of bone mass by Wnt signaling. J Clin Invest 116: 12021209.
  • 31
    Wang X Kammerer CM Wheeler VW Patrick AL Bunker CH Zmuda JM 2007 Pleiotropy and heterogeneity in the expression of bone strength-related phenotypes in extended pedigrees. J Bone Miner Res 22: 17661772.
  • 32
    Turner CH Hsieh YF Muller R Bouxsein ML Rosen CJ McCrann ME Donahue LR Beamer WG 2001 Variation in bone biomechanical properties, microstructure, and density in BXH recombinant inbred mice. J Bone Miner Res 16: 206213.
  • 33
    Kang S Bennett CN Gerin I Rapp LA Hankenson KD Macdougald OA 2007 Wnt signaling stimulates osteoblastogenesis of mesenchymal precursors by suppressing CCAAT/enhancer-binding protein alpha and peroxisome proliferator-activated receptor gamma. J Biol Chem 282: 1451514524.
  • 34
    Bennett CN Hodge CL MacDougald OA Schwartz J 2003 Role of Wnt10b and C/EBPalpha in spontaneous adipogenesis of 243 cells. Biochem Biophys Res Commun 302: 1216.
  • 35
    Longo KA Wright WS Kang S Gerin I Chiang SH Lucas PC Opp MR MacDougald OA 2004 Wnt10b inhibits development of white and brown adipose tissues. J Biol Chem 279: 3550335509.
  • 36
    Wright WS Longo KA Dolinsky VW Gerin I Kang S Bennett CN Chiang SH Prestwich TC Gress C Burant CF Susulic VS MacDougald OA 2007 Wnt10b inhibits obesity in ob/ob and agouti mice. Diabetes 56: 295303.
  • 37
    Christodoulides C Scarda A Granzotto M Milan G Dalla Nora E Keogh J De Pergola G Stirling H Pannacciulli N Sethi JK Federspil G Vidal-Puig A Farooqi IS O'Rahilly S Vettor R 2006 WNT10B mutations in human obesity. Diabetologia 49: 678684.
  • 38
    Bennett CN Ouyang H Ma YL Zeng Q Gerin I Sousa KM Lane TF Krishnan V Hankenson KD Macdougald OA 2007 Wnt10b increases postnatal bone formation by enhancing osteoblast differentiation. J Bone Miner Res 22: 19241932.
  • 39
    Akhter MP Wells DJ Short SJ Cullen DM Johnson ML Haynatzki GR Babij P Allen KM Yaworsky PJ Bex F Recker R 2004 Bone biomechanical properties in LRP5 mutant mice. Bone 35: 162169.
  • 40
    Sawakami K Robling AG Ai M Pitner ND Liu D Warden SJ Li J Maye P Rowe DW Duncan RL Warman ML Turner CH 2006 The Wnt co-receptor LRP5 is essential for skeletal mechanotransduction but not for the anabolic bone response to parathyroid hormone treatment. J Biol Chem 281: 2369823711.
  • 41
    Robinson JA Chatterjee-Kishore M Yaworsky PJ Cullen DM Zhao W Li C Kharode Y Sauter L Babij P Brown EL Hill AA Akhter MP Johnson ML Recker RR Komm BS Bex FJ 2006 Wnt/beta-catenin signaling is a normal physiological response to mechanical loading in bone. J Biol Chem 281: 3172031728.
  • 42
    Pedersen JS Bejerano G Siepel A Rosenbloom K Lindblad-Toh K Lander ES Kent J Miller W Haussler D 2006 Identification and classification of conserved RNA secondary structures in the human genome. PLOS Comput Biol 2: e33.
  • 43
    Hofacker IL 2003 Vienna RNA secondary structure server. Nucleic Acids Res 31: 34293431.
  • 44
    Nielsen KB Sørensen S Cartegni L Corydon TJ Doktor TK Schroeder LD Reinert LS Elpeleg O Krainer AR Gregersen N Kjems J Andresen BS 2007 Seemingly neutral polymorphic variants may confer immunity to splicing-inactivating mutations: A synonymous SNP in exon 5 of MCAD protects from deleterious mutations in a flanking exonic splicing enhancer. Am J Hum Genet 80: 416432.
  • 45
    Bao L Zhou M Wu L Lu L Goldowitz D Williams RW Cui Y 2007 PolymiRTS Database: Linking polymorphisms in microRNA target sites with complex traits. Nucleic Acids Res 35: D51D54.
  • 46
    Saunders MA Liang H Li WH 2007 Human polymorphism at microRNAs and microRNA target sites. Proc Natl Acad Sci USA 104: 33003305.
  • 47
    Adams BD Furneaux H White BA 2007 The micro-ribonucleic acid (miRNA) miR-206 targets the human estrogen receptor-alpha (ERalpha) and represses ERalpha messenger RNA and protein expression in breast cancer cell lines. Mol Endocrinol 21: 11321147.
  • 48
    Clop A Marcq F Takeda H Pirottin D Tordoir X Bibé B Bouix J Caiment F Elsen JM Eychenne F Larzul C Laville E Meish F Milenkovic D Tobin J Charlier C Georges M 2006 A mutation creating a potential illegitimate microRNA target site in the myostatin gene affects muscularity in sheep. Nat Genet 38: 813818.